nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CYP2E1—Dacarbazine—melanoma	0.204	0.348	CbGbCtD
Methazolamide—CYP3A4—Temozolomide—melanoma	0.147	0.251	CbGbCtD
Methazolamide—CYP2D6—Vemurafenib—melanoma	0.127	0.216	CbGbCtD
Methazolamide—CYP3A4—Vemurafenib—melanoma	0.0805	0.138	CbGbCtD
Methazolamide—CYP3A4—Docetaxel—melanoma	0.0276	0.0472	CbGbCtD
Methazolamide—CA6—ear—melanoma	0.00909	0.281	CbGeAlD
Methazolamide—Photosensitivity—Vemurafenib—melanoma	0.00603	0.0282	CcSEcCtD
Methazolamide—Digestion impaired—Temozolomide—melanoma	0.00558	0.0261	CcSEcCtD
Methazolamide—CA6—hair follicle—melanoma	0.00479	0.148	CbGeAlD
Methazolamide—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00477	0.0223	CcSEcCtD
Methazolamide—Photosensitivity reaction—Vemurafenib—melanoma	0.00418	0.0195	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00404	0.0189	CcSEcCtD
Methazolamide—Aplastic anaemia—Dactinomycin—melanoma	0.00387	0.0181	CcSEcCtD
Methazolamide—Aplastic anaemia—Temozolomide—melanoma	0.0035	0.0164	CcSEcCtD
Methazolamide—Erythema multiforme—Vemurafenib—melanoma	0.00346	0.0162	CcSEcCtD
Methazolamide—Hepatic failure—Dactinomycin—melanoma	0.00333	0.0156	CcSEcCtD
Methazolamide—Dysgeusia—Vemurafenib—melanoma	0.00312	0.0146	CcSEcCtD
Methazolamide—Hepatic failure—Temozolomide—melanoma	0.00301	0.0141	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00269	0.0126	CcSEcCtD
Methazolamide—Pancytopenia—Bleomycin—melanoma	0.00263	0.0123	CcSEcCtD
Methazolamide—Anaphylactic shock—Vemurafenib—melanoma	0.0026	0.0122	CcSEcCtD
Methazolamide—Pancytopenia—Dactinomycin—melanoma	0.00245	0.0115	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00244	0.0114	CcSEcCtD
Methazolamide—Haematuria—Bleomycin—melanoma	0.00236	0.011	CcSEcCtD
Methazolamide—Pancytopenia—Carmustine—melanoma	0.0023	0.0107	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00229	0.0107	CcSEcCtD
Methazolamide—Decreased appetite—Vemurafenib—melanoma	0.00226	0.0106	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Vemurafenib—melanoma	0.00225	0.0105	CcSEcCtD
Methazolamide—Fatigue—Vemurafenib—melanoma	0.00224	0.0105	CcSEcCtD
Methazolamide—Pancytopenia—Temozolomide—melanoma	0.00222	0.0104	CcSEcCtD
Methazolamide—Agranulocytosis—Dactinomycin—melanoma	0.00215	0.0101	CcSEcCtD
Methazolamide—Photosensitivity reaction—Temozolomide—melanoma	0.00213	0.00997	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00207	0.00966	CcSEcCtD
Methazolamide—Body temperature increased—Vemurafenib—melanoma	0.00206	0.00961	CcSEcCtD
Methazolamide—Hepatic failure—Docetaxel—melanoma	0.002	0.00936	CcSEcCtD
Methazolamide—Erythema multiforme—Dactinomycin—melanoma	0.00196	0.00914	CcSEcCtD
Methazolamide—Asthenia—Vemurafenib—melanoma	0.00187	0.00872	CcSEcCtD
Methazolamide—Ill-defined disorder—Bleomycin—melanoma	0.00179	0.00837	CcSEcCtD
Methazolamide—Diarrhoea—Vemurafenib—melanoma	0.00178	0.00832	CcSEcCtD
Methazolamide—Erythema multiforme—Temozolomide—melanoma	0.00177	0.00827	CcSEcCtD
Methazolamide—Tinnitus—Temozolomide—melanoma	0.00174	0.00816	CcSEcCtD
Methazolamide—Malaise—Bleomycin—melanoma	0.00174	0.00814	CcSEcCtD
Methazolamide—Leukopenia—Bleomycin—melanoma	0.00173	0.00808	CcSEcCtD
Methazolamide—Ill-defined disorder—Dactinomycin—melanoma	0.00167	0.00781	CcSEcCtD
Methazolamide—Vomiting—Vemurafenib—melanoma	0.00165	0.00773	CcSEcCtD
Methazolamide—CA2—hair follicle—melanoma	0.00165	0.0511	CbGeAlD
Methazolamide—Rash—Vemurafenib—melanoma	0.00164	0.00767	CcSEcCtD
Methazolamide—Dermatitis—Vemurafenib—melanoma	0.00164	0.00766	CcSEcCtD
Methazolamide—Headache—Vemurafenib—melanoma	0.00163	0.00762	CcSEcCtD
Methazolamide—Discomfort—Bleomycin—melanoma	0.00162	0.00759	CcSEcCtD
Methazolamide—Malaise—Dactinomycin—melanoma	0.00162	0.00759	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00162	0.00757	CcSEcCtD
Methazolamide—Leukopenia—Dactinomycin—melanoma	0.00161	0.00754	CcSEcCtD
Methazolamide—CA12—eye—melanoma	0.0016	0.0496	CbGeAlD
Methazolamide—Dysgeusia—Temozolomide—melanoma	0.0016	0.00746	CcSEcCtD
Methazolamide—Confusional state—Bleomycin—melanoma	0.00159	0.00743	CcSEcCtD
Methazolamide—Anaphylactic shock—Bleomycin—melanoma	0.00158	0.00737	CcSEcCtD
Methazolamide—Nausea—Vemurafenib—melanoma	0.00155	0.00722	CcSEcCtD
Methazolamide—Discomfort—Dactinomycin—melanoma	0.00152	0.00708	CcSEcCtD
Methazolamide—Ill-defined disorder—Temozolomide—melanoma	0.00151	0.00706	CcSEcCtD
Methazolamide—Leukopenia—Carmustine—melanoma	0.00151	0.00705	CcSEcCtD
Methazolamide—Anorexia—Bleomycin—melanoma	0.0015	0.00702	CcSEcCtD
Methazolamide—Pancytopenia—Docetaxel—melanoma	0.00148	0.0069	CcSEcCtD
Methazolamide—Malaise—Temozolomide—melanoma	0.00147	0.00687	CcSEcCtD
Methazolamide—Vertigo—Temozolomide—melanoma	0.00146	0.00684	CcSEcCtD
Methazolamide—Convulsion—Carmustine—melanoma	0.00146	0.00683	CcSEcCtD
Methazolamide—Leukopenia—Temozolomide—melanoma	0.00146	0.00682	CcSEcCtD
Methazolamide—Paraesthesia—Bleomycin—melanoma	0.00142	0.00661	CcSEcCtD
Methazolamide—Convulsion—Temozolomide—melanoma	0.00141	0.0066	CcSEcCtD
Methazolamide—Anorexia—Dactinomycin—melanoma	0.0014	0.00655	CcSEcCtD
Methazolamide—Confusional state—Carmustine—melanoma	0.00139	0.00648	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00137	0.00642	CcSEcCtD
Methazolamide—Discomfort—Temozolomide—melanoma	0.00137	0.0064	CcSEcCtD
Methazolamide—Decreased appetite—Bleomycin—melanoma	0.00137	0.0064	CcSEcCtD
Methazolamide—CA6—head—melanoma	0.00136	0.042	CbGeAlD
Methazolamide—Confusional state—Temozolomide—melanoma	0.00134	0.00627	CcSEcCtD
Methazolamide—CA4—neck—melanoma	0.00134	0.0413	CbGeAlD
Methazolamide—Anaphylactic shock—Temozolomide—melanoma	0.00133	0.00621	CcSEcCtD
Methazolamide—Anorexia—Carmustine—melanoma	0.00131	0.00613	CcSEcCtD
Methazolamide—Feeling abnormal—Bleomycin—melanoma	0.0013	0.00607	CcSEcCtD
Methazolamide—Agranulocytosis—Docetaxel—melanoma	0.00129	0.00605	CcSEcCtD
Methazolamide—Decreased appetite—Dactinomycin—melanoma	0.00128	0.00597	CcSEcCtD
Methazolamide—CA1—eye—melanoma	0.00127	0.0393	CbGeAlD
Methazolamide—Fatigue—Dactinomycin—melanoma	0.00127	0.00592	CcSEcCtD
Methazolamide—Anorexia—Temozolomide—melanoma	0.00127	0.00592	CcSEcCtD
Methazolamide—Urticaria—Bleomycin—melanoma	0.00125	0.00585	CcSEcCtD
Methazolamide—Body temperature increased—Bleomycin—melanoma	0.00125	0.00582	CcSEcCtD
Methazolamide—Paraesthesia—Carmustine—melanoma	0.00124	0.00577	CcSEcCtD
Methazolamide—Somnolence—Carmustine—melanoma	0.00122	0.00572	CcSEcCtD
Methazolamide—Feeling abnormal—Dactinomycin—melanoma	0.00121	0.00566	CcSEcCtD
Methazolamide—Decreased appetite—Carmustine—melanoma	0.0012	0.00559	CcSEcCtD
Methazolamide—Paraesthesia—Temozolomide—melanoma	0.00119	0.00558	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Carmustine—melanoma	0.00119	0.00555	CcSEcCtD
Methazolamide—Somnolence—Temozolomide—melanoma	0.00118	0.00552	CcSEcCtD
Methazolamide—Erythema multiforme—Docetaxel—melanoma	0.00118	0.0055	CcSEcCtD
Methazolamide—Dyspepsia—Temozolomide—melanoma	0.00117	0.00547	CcSEcCtD
Methazolamide—Body temperature increased—Dactinomycin—melanoma	0.00116	0.00543	CcSEcCtD
Methazolamide—Decreased appetite—Temozolomide—melanoma	0.00116	0.0054	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Temozolomide—melanoma	0.00115	0.00536	CcSEcCtD
Methazolamide—Fatigue—Temozolomide—melanoma	0.00115	0.00536	CcSEcCtD
Methazolamide—CA5B—mammalian vulva—melanoma	0.00114	0.0353	CbGeAlD
Methazolamide—Feeling abnormal—Carmustine—melanoma	0.00113	0.0053	CcSEcCtD
Methazolamide—Asthenia—Bleomycin—melanoma	0.00113	0.00529	CcSEcCtD
Methazolamide—CA2—neck—melanoma	0.00111	0.0343	CbGeAlD
Methazolamide—Feeling abnormal—Temozolomide—melanoma	0.0011	0.00512	CcSEcCtD
Methazolamide—Body temperature increased—Carmustine—melanoma	0.00109	0.00508	CcSEcCtD
Methazolamide—Dysgeusia—Docetaxel—melanoma	0.00106	0.00496	CcSEcCtD
Methazolamide—Urticaria—Temozolomide—melanoma	0.00106	0.00494	CcSEcCtD
Methazolamide—Asthenia—Dactinomycin—melanoma	0.00105	0.00493	CcSEcCtD
Methazolamide—Body temperature increased—Temozolomide—melanoma	0.00105	0.00491	CcSEcCtD
Methazolamide—Diarrhoea—Dactinomycin—melanoma	0.00101	0.0047	CcSEcCtD
Methazolamide—Vomiting—Bleomycin—melanoma	0.001	0.00468	CcSEcCtD
Methazolamide—Rash—Bleomycin—melanoma	0.000994	0.00464	CcSEcCtD
Methazolamide—Dermatitis—Bleomycin—melanoma	0.000993	0.00464	CcSEcCtD
Methazolamide—Asthenia—Carmustine—melanoma	0.000987	0.00461	CcSEcCtD
Methazolamide—Leukopenia—Docetaxel—melanoma	0.00097	0.00453	CcSEcCtD
Methazolamide—Asthenia—Temozolomide—melanoma	0.000954	0.00446	CcSEcCtD
Methazolamide—Diarrhoea—Carmustine—melanoma	0.000941	0.0044	CcSEcCtD
Methazolamide—Convulsion—Docetaxel—melanoma	0.000939	0.00439	CcSEcCtD
Methazolamide—Nausea—Bleomycin—melanoma	0.000936	0.00438	CcSEcCtD
Methazolamide—Vomiting—Dactinomycin—melanoma	0.000935	0.00437	CcSEcCtD
Methazolamide—Rash—Dactinomycin—melanoma	0.000927	0.00433	CcSEcCtD
Methazolamide—CA12—head—melanoma	0.000911	0.0282	CbGeAlD
Methazolamide—Diarrhoea—Temozolomide—melanoma	0.00091	0.00425	CcSEcCtD
Methazolamide—Confusional state—Docetaxel—melanoma	0.000892	0.00417	CcSEcCtD
Methazolamide—Anaphylactic shock—Docetaxel—melanoma	0.000884	0.00413	CcSEcCtD
Methazolamide—Vomiting—Carmustine—melanoma	0.000875	0.00409	CcSEcCtD
Methazolamide—Nausea—Dactinomycin—melanoma	0.000873	0.00408	CcSEcCtD
Methazolamide—Rash—Carmustine—melanoma	0.000868	0.00405	CcSEcCtD
Methazolamide—Dermatitis—Carmustine—melanoma	0.000867	0.00405	CcSEcCtD
Methazolamide—Headache—Carmustine—melanoma	0.000862	0.00403	CcSEcCtD
Methazolamide—Vomiting—Temozolomide—melanoma	0.000845	0.00395	CcSEcCtD
Methazolamide—Anorexia—Docetaxel—melanoma	0.000843	0.00394	CcSEcCtD
Methazolamide—Rash—Temozolomide—melanoma	0.000838	0.00392	CcSEcCtD
Methazolamide—Dermatitis—Temozolomide—melanoma	0.000838	0.00391	CcSEcCtD
Methazolamide—Headache—Temozolomide—melanoma	0.000833	0.00389	CcSEcCtD
Methazolamide—CA2—eye—melanoma	0.000824	0.0255	CbGeAlD
Methazolamide—Nausea—Carmustine—melanoma	0.000817	0.00382	CcSEcCtD
Methazolamide—CA5B—head—melanoma	0.000817	0.0253	CbGeAlD
Methazolamide—CA2—retina—melanoma	0.000816	0.0253	CbGeAlD
Methazolamide—Paraesthesia—Docetaxel—melanoma	0.000794	0.00371	CcSEcCtD
Methazolamide—Nausea—Temozolomide—melanoma	0.00079	0.00369	CcSEcCtD
Methazolamide—Somnolence—Docetaxel—melanoma	0.000786	0.00367	CcSEcCtD
Methazolamide—Dyspepsia—Docetaxel—melanoma	0.000778	0.00364	CcSEcCtD
Methazolamide—Decreased appetite—Docetaxel—melanoma	0.000769	0.00359	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Docetaxel—melanoma	0.000763	0.00357	CcSEcCtD
Methazolamide—Fatigue—Docetaxel—melanoma	0.000762	0.00356	CcSEcCtD
Methazolamide—Feeling abnormal—Docetaxel—melanoma	0.000729	0.00341	CcSEcCtD
Methazolamide—CA1—head—melanoma	0.000721	0.0223	CbGeAlD
Methazolamide—CA2—skin of body—melanoma	0.000717	0.0222	CbGeAlD
Methazolamide—Body temperature increased—Docetaxel—melanoma	0.000699	0.00327	CcSEcCtD
Methazolamide—CA2—mammalian vulva—melanoma	0.000653	0.0202	CbGeAlD
Methazolamide—Asthenia—Docetaxel—melanoma	0.000634	0.00296	CcSEcCtD
Methazolamide—Diarrhoea—Docetaxel—melanoma	0.000605	0.00283	CcSEcCtD
Methazolamide—CA5B—lymph node—melanoma	0.000572	0.0177	CbGeAlD
Methazolamide—CA4—head—melanoma	0.000564	0.0174	CbGeAlD
Methazolamide—Vomiting—Docetaxel—melanoma	0.000562	0.00263	CcSEcCtD
Methazolamide—Rash—Docetaxel—melanoma	0.000558	0.00261	CcSEcCtD
Methazolamide—Dermatitis—Docetaxel—melanoma	0.000557	0.0026	CcSEcCtD
Methazolamide—Headache—Docetaxel—melanoma	0.000554	0.00259	CcSEcCtD
Methazolamide—Nausea—Docetaxel—melanoma	0.000525	0.00245	CcSEcCtD
Methazolamide—CA1—lymph node—melanoma	0.000505	0.0156	CbGeAlD
Methazolamide—CA2—head—melanoma	0.000468	0.0145	CbGeAlD
Methazolamide—CA4—lymph node—melanoma	0.000395	0.0122	CbGeAlD
Methazolamide—CYP2E1—head—melanoma	0.000375	0.0116	CbGeAlD
Methazolamide—CA2—lymph node—melanoma	0.000327	0.0101	CbGeAlD
Methazolamide—CYP2D6—head—melanoma	0.000297	0.00919	CbGeAlD
Methazolamide—CA12—Metabolism—ALB—melanoma	5.95e-05	0.000353	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PIK3CB—melanoma	5.67e-05	0.000336	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PIK3CB—melanoma	5.67e-05	0.000336	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PRKCA—melanoma	5.64e-05	0.000334	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PTGS2—melanoma	5.62e-05	0.000333	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PTGS2—melanoma	5.62e-05	0.000333	CbGpPWpGaD
Methazolamide—CA9—Metabolism—ERCC2—melanoma	5.59e-05	0.000332	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	5.56e-05	0.000329	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—LUM—melanoma	5.53e-05	0.000328	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PHGDH—melanoma	5.53e-05	0.000328	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PIK3CG—melanoma	5.46e-05	0.000324	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—HPSE—melanoma	5.42e-05	0.000321	CbGpPWpGaD
Methazolamide—CA14—Metabolism—PTEN—melanoma	5.38e-05	0.000319	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CUBN—melanoma	5.32e-05	0.000315	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PPARG—melanoma	5.27e-05	0.000313	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PIK3CB—melanoma	5.25e-05	0.000311	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—PTEN—melanoma	5.25e-05	0.000311	CbGpPWpGaD
Methazolamide—CA6—Metabolism—PTEN—melanoma	5.25e-05	0.000311	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PIK3CG—melanoma	5.24e-05	0.000311	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PLCB4—melanoma	5.23e-05	0.00031	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PTGS2—melanoma	5.2e-05	0.000308	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—SDHD—melanoma	5.14e-05	0.000305	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CSPG4—melanoma	5.14e-05	0.000305	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—BSG—melanoma	5.14e-05	0.000305	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—FASN—melanoma	5.13e-05	0.000304	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	5.07e-05	0.0003	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PPARG—melanoma	5.06e-05	0.0003	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PIK3CG—melanoma	5.02e-05	0.000298	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GPAM—melanoma	4.98e-05	0.000295	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIP4K2A—melanoma	4.92e-05	0.000292	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SLC6A11—melanoma	4.92e-05	0.000292	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—ALB—melanoma	4.91e-05	0.000291	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PTEN—melanoma	4.9e-05	0.00029	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PTEN—melanoma	4.9e-05	0.00029	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ACER3—melanoma	4.88e-05	0.000289	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PPARG—melanoma	4.85e-05	0.000287	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PLCB4—melanoma	4.81e-05	0.000285	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PIK3CD—melanoma	4.8e-05	0.000285	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MTAP—melanoma	4.78e-05	0.000284	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PLCB4—melanoma	4.77e-05	0.000283	CbGpPWpGaD
Methazolamide—CA4—Metabolism—ALB—melanoma	4.74e-05	0.000281	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	4.68e-05	0.000278	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4.68e-05	0.000277	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PIK3CD—melanoma	4.61e-05	0.000273	CbGpPWpGaD
Methazolamide—CA2—Metabolism—ALB—melanoma	4.55e-05	0.00027	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PTEN—melanoma	4.54e-05	0.000269	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIP4K2A—melanoma	4.52e-05	0.000268	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SLC6A11—melanoma	4.52e-05	0.000268	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC6A11—melanoma	4.48e-05	0.000266	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIP4K2A—melanoma	4.48e-05	0.000266	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—UGT2B10—melanoma	4.46e-05	0.000265	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PIK3CG—melanoma	4.42e-05	0.000262	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PIK3CD—melanoma	4.42e-05	0.000262	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MTAP—melanoma	4.4e-05	0.000261	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MTAP—melanoma	4.36e-05	0.000259	CbGpPWpGaD
Methazolamide—CA1—Metabolism—ALB—melanoma	4.36e-05	0.000258	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PHGDH—melanoma	4.26e-05	0.000253	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—LUM—melanoma	4.26e-05	0.000253	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4.26e-05	0.000253	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PPARG—melanoma	4.26e-05	0.000253	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PLA2G6—melanoma	4.23e-05	0.000251	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PIK3CB—melanoma	4.19e-05	0.000248	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HPSE—melanoma	4.18e-05	0.000248	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HS3ST5—melanoma	4.15e-05	0.000246	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PTGS2—melanoma	4.15e-05	0.000246	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CUBN—melanoma	4.1e-05	0.000243	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PIK3CB—melanoma	4.01e-05	0.000238	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PTGS2—melanoma	3.98e-05	0.000236	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SDHD—melanoma	3.96e-05	0.000235	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—BSG—melanoma	3.96e-05	0.000235	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CSPG4—melanoma	3.96e-05	0.000235	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—LUM—melanoma	3.92e-05	0.000233	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PHGDH—melanoma	3.92e-05	0.000233	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PHGDH—melanoma	3.89e-05	0.000231	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—LUM—melanoma	3.89e-05	0.000231	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PIK3CD—melanoma	3.88e-05	0.00023	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PIK3CB—melanoma	3.85e-05	0.000228	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HPSE—melanoma	3.85e-05	0.000228	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GPAM—melanoma	3.84e-05	0.000228	CbGpPWpGaD
Methazolamide—CA9—Metabolism—ALB—melanoma	3.83e-05	0.000227	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PTGS2—melanoma	3.81e-05	0.000226	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HPSE—melanoma	3.81e-05	0.000226	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—VCAN—melanoma	3.8e-05	0.000225	CbGpPWpGaD
Methazolamide—CA14—Metabolism—PIK3CA—melanoma	3.8e-05	0.000225	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CUBN—melanoma	3.78e-05	0.000224	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CUBN—melanoma	3.74e-05	0.000222	CbGpPWpGaD
Methazolamide—CA6—Metabolism—PIK3CA—melanoma	3.7e-05	0.000219	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—PIK3CA—melanoma	3.7e-05	0.000219	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SDHD—melanoma	3.65e-05	0.000216	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CSPG4—melanoma	3.65e-05	0.000216	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—BSG—melanoma	3.65e-05	0.000216	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PTEN—melanoma	3.62e-05	0.000215	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SDHD—melanoma	3.61e-05	0.000214	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—BSG—melanoma	3.61e-05	0.000214	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CSPG4—melanoma	3.61e-05	0.000214	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GPAM—melanoma	3.53e-05	0.000209	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GPAM—melanoma	3.5e-05	0.000208	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PTEN—melanoma	3.47e-05	0.000206	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PIK3CA—melanoma	3.46e-05	0.000205	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PIK3CA—melanoma	3.46e-05	0.000205	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PIK3CB—melanoma	3.38e-05	0.000201	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PTGS2—melanoma	3.35e-05	0.000199	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PTEN—melanoma	3.33e-05	0.000197	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PLA2G6—melanoma	3.26e-05	0.000194	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP17A1—melanoma	3.21e-05	0.00019	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PIK3CA—melanoma	3.2e-05	0.00019	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PLCB4—melanoma	3.15e-05	0.000187	CbGpPWpGaD
Methazolamide—CA14—Metabolism—AKT1—melanoma	3.1e-05	0.000184	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GNA11—melanoma	3.03e-05	0.00018	CbGpPWpGaD
Methazolamide—CA6—Metabolism—AKT1—melanoma	3.02e-05	0.000179	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—AKT1—melanoma	3.02e-05	0.000179	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PLA2G6—melanoma	3e-05	0.000178	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PLA2G6—melanoma	2.98e-05	0.000177	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—FASN—melanoma	2.96e-05	0.000176	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIP4K2A—melanoma	2.96e-05	0.000175	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC6A11—melanoma	2.96e-05	0.000175	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—VCAN—melanoma	2.93e-05	0.000174	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PTEN—melanoma	2.92e-05	0.000173	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—SLC5A5—melanoma	2.92e-05	0.000173	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MTAP—melanoma	2.88e-05	0.000171	CbGpPWpGaD
Methazolamide—CA7—Metabolism—AKT1—melanoma	2.82e-05	0.000167	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—AKT1—melanoma	2.82e-05	0.000167	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GNAQ—melanoma	2.82e-05	0.000167	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CD44—melanoma	2.82e-05	0.000167	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.78e-05	0.000165	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP1B1—melanoma	2.7e-05	0.00016	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—VCAN—melanoma	2.7e-05	0.00016	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.68e-05	0.000159	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—VCAN—melanoma	2.67e-05	0.000159	CbGpPWpGaD
Methazolamide—CA12—Metabolism—AKT1—melanoma	2.61e-05	0.000155	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PHGDH—melanoma	2.56e-05	0.000152	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—LUM—melanoma	2.56e-05	0.000152	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PIK3CA—melanoma	2.55e-05	0.000151	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.53e-05	0.00015	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HPSE—melanoma	2.51e-05	0.000149	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP17A1—melanoma	2.47e-05	0.000147	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CUBN—melanoma	2.47e-05	0.000146	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PIK3CA—melanoma	2.45e-05	0.000145	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.44e-05	0.000145	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.44e-05	0.000145	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	2.41e-05	0.000143	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SDHD—melanoma	2.38e-05	0.000141	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—BSG—melanoma	2.38e-05	0.000141	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CSPG4—melanoma	2.38e-05	0.000141	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PIK3CA—melanoma	2.35e-05	0.000139	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GNA11—melanoma	2.34e-05	0.000139	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GPAM—melanoma	2.31e-05	0.000137	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—FASN—melanoma	2.29e-05	0.000136	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP17A1—melanoma	2.28e-05	0.000135	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP17A1—melanoma	2.26e-05	0.000134	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SLC5A5—melanoma	2.25e-05	0.000133	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.22e-05	0.000132	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ABCB1—melanoma	2.22e-05	0.000132	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	2.2e-05	0.00013	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GNAQ—melanoma	2.17e-05	0.000129	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CD44—melanoma	2.17e-05	0.000129	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GNA11—melanoma	2.15e-05	0.000127	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GNA11—melanoma	2.13e-05	0.000126	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.13e-05	0.000126	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.11e-05	0.000125	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—FASN—melanoma	2.1e-05	0.000125	CbGpPWpGaD
Methazolamide—CA4—Metabolism—AKT1—melanoma	2.09e-05	0.000124	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—FASN—melanoma	2.08e-05	0.000124	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP1B1—melanoma	2.08e-05	0.000123	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SLC5A5—melanoma	2.07e-05	0.000123	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PIK3CA—melanoma	2.06e-05	0.000122	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC5A5—melanoma	2.05e-05	0.000122	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PRKCA—melanoma	2.05e-05	0.000121	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ERCC2—melanoma	2.03e-05	0.00012	CbGpPWpGaD
Methazolamide—CA2—Metabolism—AKT1—melanoma	2e-05	0.000119	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GNAQ—melanoma	2e-05	0.000118	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CD44—melanoma	2e-05	0.000118	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GNAQ—melanoma	1.98e-05	0.000117	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CD44—melanoma	1.98e-05	0.000117	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PLA2G6—melanoma	1.96e-05	0.000116	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.94e-05	0.000115	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.92e-05	0.000114	CbGpPWpGaD
Methazolamide—CA1—Metabolism—AKT1—melanoma	1.92e-05	0.000114	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP1B1—melanoma	1.92e-05	0.000114	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP1B1—melanoma	1.9e-05	0.000113	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.84e-05	0.000109	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—VCAN—melanoma	1.76e-05	0.000105	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ABCB1—melanoma	1.71e-05	0.000102	CbGpPWpGaD
Methazolamide—CA9—Metabolism—AKT1—melanoma	1.69e-05	9.99e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.68e-05	9.94e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CG—melanoma	1.6e-05	9.5e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PRKCA—melanoma	1.58e-05	9.36e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ABCB1—melanoma	1.58e-05	9.35e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ERCC2—melanoma	1.57e-05	9.28e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ABCB1—melanoma	1.56e-05	9.27e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PPARG—melanoma	1.55e-05	9.17e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP17A1—melanoma	1.49e-05	8.82e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PRKCA—melanoma	1.45e-05	8.61e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ERCC2—melanoma	1.44e-05	8.54e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PRKCA—melanoma	1.44e-05	8.53e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ERCC2—melanoma	1.43e-05	8.46e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CD—melanoma	1.41e-05	8.35e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GNA11—melanoma	1.41e-05	8.33e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ALB—melanoma	1.39e-05	8.24e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—FASN—melanoma	1.37e-05	8.15e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC5A5—melanoma	1.35e-05	8.02e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GNAQ—melanoma	1.31e-05	7.75e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CD44—melanoma	1.31e-05	7.75e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.3e-05	7.69e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP1B1—melanoma	1.25e-05	7.43e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CG—melanoma	1.24e-05	7.33e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CB—melanoma	1.23e-05	7.28e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PTGS2—melanoma	1.22e-05	7.21e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PPARG—melanoma	1.19e-05	7.07e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.18e-05	7.01e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CG—melanoma	1.14e-05	6.74e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CG—melanoma	1.13e-05	6.68e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PPARG—melanoma	1.1e-05	6.51e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PPARG—melanoma	1.09e-05	6.45e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CD—melanoma	1.09e-05	6.44e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALB—melanoma	1.07e-05	6.36e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PTEN—melanoma	1.06e-05	6.29e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ABCB1—melanoma	1.03e-05	6.11e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CD—melanoma	1e-05	5.93e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CD—melanoma	9.91e-06	5.88e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALB—melanoma	9.87e-06	5.85e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALB—melanoma	9.78e-06	5.8e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PRKCA—melanoma	9.49e-06	5.63e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CB—melanoma	9.47e-06	5.62e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ERCC2—melanoma	9.41e-06	5.58e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTGS2—melanoma	9.39e-06	5.57e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CB—melanoma	8.71e-06	5.17e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CB—melanoma	8.64e-06	5.12e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTGS2—melanoma	8.63e-06	5.12e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTGS2—melanoma	8.56e-06	5.07e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTEN—melanoma	8.19e-06	4.85e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTEN—melanoma	7.53e-06	4.46e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CA—melanoma	7.48e-06	4.44e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTEN—melanoma	7.46e-06	4.43e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CG—melanoma	7.43e-06	4.41e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PPARG—melanoma	7.17e-06	4.25e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CD—melanoma	6.54e-06	3.87e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALB—melanoma	6.45e-06	3.83e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AKT1—melanoma	6.11e-06	3.63e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CA—melanoma	5.77e-06	3.42e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CB—melanoma	5.7e-06	3.38e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTGS2—melanoma	5.64e-06	3.35e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CA—melanoma	5.31e-06	3.15e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CA—melanoma	5.27e-06	3.12e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTEN—melanoma	4.92e-06	2.92e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AKT1—melanoma	4.72e-06	2.8e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AKT1—melanoma	4.34e-06	2.57e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AKT1—melanoma	4.3e-06	2.55e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CA—melanoma	3.47e-06	2.06e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AKT1—melanoma	2.84e-06	1.68e-05	CbGpPWpGaD
